Hopital Saint-Louis

Paris, Cedex 10 75475

0 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, HIV Infections, Solid Tumor, Ulcerative Colitis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Study of LY3200882 in Participants With Solid Tumors — Running, not enrolling
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) — Completed
• Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects — Completed